邹董一行专心致志地参观了易特科集团产品展示区，了解了诺奖科学家Edvard I. Moser教授和Craig C. Mello教授主导的“智慧医疗诺奖实验室”研究项目，仔细咨询了易特科（前海安测）健康化、智能化、高端化医疗大健康建设情况，饶有兴致地体验了安测健康智能一体机、安测中医四诊仪等信息化产品，自助体检血压、血糖、心电等项目。
On December 28th, 2018, Mr. Zou Xingcheng, the deputy director of UBS, led the core team to visit E-Techco (Qianhai AnyCheck) Shenzhen headquarters to inspect AI medical innovation projects and exchange medical information and medical big data applications. Mr. Zhang Guanjing, Chairman and CEO of E-Techco (Qianhai AnyCheck), Vice Chairman Ms. Xiao Yingfen, Vice President Mr. Wang Hairong, CTO Dr. Ge Xinke, Chief Engineer and General Manager of Investment Department Dr. Gao Weiming, Deputy Chief Engineer Dr. Zhang Hongzhi, Investment The deputy general manager of the department, Mr. Ren Wendong, Senior Sales Manager Mr. Fu Wenzheng and Mr. Zhao Kangfu and other core teams accompanied by the whole team Inspected and explained to Mr. Zou and his team in detail the construction and progress of the E-Techco (Qianhai AnyCheck) AI medical project.
Mr. Zou and his entourage visited the E-Techco Group's product display area and learned about the “Smart Medical Nobel Prize Lab” research project led by Professor Edvard I. Moser and Professor Craig C. Mello. They consulted E-Techco (Qianhai AnyCheck) Health, intelligent, high-end medical care and health construction, and have experienced the information technology products such as AnyCheck Health Smart Integrated Machine, AnyCheck Traditional Chinese Medicine, and self-checking blood pressure, blood glucose and heart rate.
After experiencing the products and services on site, the delegation expressed high recognition for E-Techco Group's planning, layout, research and innovation in the field of medical health, and affirmed the work attitude of project personnel in research and development and innovation.
During the discussion, Chairman Zhang Guanjing mentioned that E-Techco Group, with the support of major banking systems and financial institutions, has comprehensively promoted production management, brand building, intelligent upgrading, and AI medical project construction. At present, E-Techco Group is firmly grasping strategic opportunities, vigorously promoting the construction of “AI+Medical+Health+Elderly Care” and actively building it into a demonstration point for the national smart medical industry. E-Techco (Qianhai AnyCheck) hope to deepen cooperation with UBS to develop and support E-Techco Group to realize IPO at an early date, bring more efficient and convenient medical and health services to more people, help build China, and realize humanity healthy dreams, E-Techco's Chinese dream.
The inspection team said that through this investigation, we deeply understand that E-Techco Group is at the forefront of AI medical innovation, and all aspects of work have maintained a healthy and good upward trend. E-Techco Group's development philosophy, strategic planning science, and development achievements are gratifying. The prospects are broad, attracting a lot of government and bank investment institutions to pay close attention. It is hoped that both sides can accelerate the promotion of comprehensive strategic cooperation, and provide services such as artificial intelligence, big data, and deep learning to serve the medical informationization and health industry, and improve the quality of health services.